SCHEMBL2841728

SCHEMBL2841728

CN1CCC(Oc2ccc(Cl)c(Cl)c2)c2sccc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HSP90AA1 P07900 1/20 0.37
HSP90AB1 P08238 1/20 0.37
SLC6A5 Q9Y345 1/20 0.37
CHRNA3 P32297 1/20 0.36
HRH4 Q9H3N8 1/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A2 P23975 2/20 0.36
SLC6A3 Q01959 2/20 0.36
FPR2 P25090 1/20 0.35
PROKR1 Q8TCW9 1/20 0.35
OPRD1 P41143 1/20 0.35
UTS2R Q9UKP6 1/20 0.35
GAA P10253 1/20 0.34
HRH1 P35367 1/20 0.34
CCR3 P51677 1/20 0.34
KCNH2 Q12809 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2845761 0.99 KDM4E (0.40) KDM4EALDH1A1HSP90AA1HSP90AB1SLC6A5
SCHEMBL2843973 0.88 SLC6A4 (0.38) KDM4EALDH1A1SLC6A5HRH4SLC6A4
SCHEMBL2838984 0.82 KDM4E (0.37) KDM4EALDH1A1HSP90AA1HSP90AB1SLC6A5
Hydrochloric Acid SCHEMBL2836930 0.82 TP53 (0.34) ALDH1A1SLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL2835085 0.82 RYR2 (0.34) ALDH1A1SLC6A4SLC6A2SLC6A3GAA
Hydrochloric Acid SCHEMBL2845465 0.82 SLC6A2 (0.40) KDM4EALDH1A1HSP90AA1HSP90AB1CHRNA3
SCHEMBL2839785 0.81 KDM4E (0.38) KDM4EALDH1A1HRH4SLC6A4SLC6A2
Hydrochloric Acid SCHEMBL2844346 0.80 MEN1 (0.32) LMNADRD2
SCHEMBL2837080 0.78 POLB (0.38) ALDH1A1SLC6A4SLC6A2SLC6A3KCNH2
Hydrochloric Acid SCHEMBL2841036 0.78 TP53 (0.31) ALDH1A1CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 KDM4E 3292/4885ALDH1A1 66/4885HSP90AA1 526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.